Bhaskar Anand's Net Worth
$512 Thousand
Who is Bhaskar Anand?
Bhaskar Anand does not have any significant net worth to report based on the numbers we have. This is based on reported shares in REATA PHARMACEUTICALS INC.
SEC CIK
Bhaskar Anand's CIK is 0001890784
Past Insider Trading and Trends
2023 was Bhaskar Anand's most active year for acquiring shares with 5 total transactions. Bhaskar Anand's most active month to acquire stocks was the month of December. 2023 was Bhaskar Anand's most active year for disposing of shares, totalling 14 transactions. Bhaskar Anand's most active month to dispose stocks was the month of August. 2023 saw Bhaskar Anand paying a total of $42,673.84 for 52,312 shares, this is the most they've acquired in one year. In 2023 Bhaskar Anand cashed out on 108,812 shares for a total of $554,333.97, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
REATA PHARMACEUTICALS INC No price found
SVP, Chief Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -24.09K |
—
|
—
|
0
|
Sep 26
| |||
Form 4
| -1.66% | -406.00 |
$169.20 | -$68,695.20 | 24.09K |
Sep 5
| |||
Form 4
| -1.62% | -403.00 |
$168.72 | -$67,995.48 | 24.5K |
Aug 15 - Aug 16
| |||
Form 4
| -3.04% | -781.00 |
$64.72 | -$196,574.11 | 24.9K |
Jun 14
| |||
Form 4
| -4.06% | -1.09K |
$85.37 | -$92,714.25 | 25.68K |
May 15 - May 16
| |||
Form 4
| -0.61% | -165.00 |
$84.58 | -$13,955.70 | 26.77K |
Mar 7
| |||
Form 4
| -2.95% | -820.00 |
$87.47 | -$71,725.40 | 26.93K |
Mar 3
| |||
Form 4
| +12.12% | 3K |
—
|
—
| 27.75K |
Mar 1
| |||
Form 4
| +50.00% | 8.25K |
—
|
—
| 24.75K |
Jan 3
| |||
Form 4
| +312.50% | 12.5K |
—
|
—
| 16.5K |
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Summit Therapeutics Inc. (SMMT) No price found
Chief Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||